toremifene
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
March 07, 2023
Elacestrant (Orserdu) for advanced or metastatic breast cancer.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Metastases • Breast Cancer • Oncology • Solid Tumor
September 04, 2019
Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer
(clinicaltrials.gov)
- P2; N=96; Recruiting; Sponsor: N.N. Petrov National Medical Research Center of Oncology; Trial completion date: Aug 2017 ➔ Aug 2022; Trial primary completion date: Aug 2017 ➔ Aug 2020
Clinical • Trial completion date • Trial primary completion date
March 06, 2018
Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer.
(PubMed, Am J Surg)
- "In a group of hormone-sensitive, mostly postmenopausal early-stage breast cancer patients, palpable tumors were more likely to have more aggressive features and metastatic potential, which translated in to a higher incidence of breast cancer-related events and worse overall survival."
Journal
April 09, 2019
TTOS: Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer
(clinicaltrials.gov)
- P4; N=126; Completed; Sponsor: Shanghai Jiao Tong University School of Medicine; Active, not recruiting ➔ Completed
Clinical • Trial completion
1 to 4
Of
4
Go to page
1